马钱子配伍苏木对关节炎大鼠抗炎及免疫机制的影响  被引量:5

Effect of Anti-Inflammatory and Immunologic Mechanism on Rats with Arthritis Treated with Maqianzi and Sumu

在线阅读下载全文

作  者:梁晓东[1,2] 边月娟 李茜[2] 唐迎雪[2] 

机构地区:[1]中国中医科学院西苑医院老年病研究所,北京100091 [2]山东中医药大学中医学院,山东济南250355 [3]American Academy of Acupuncture and Oriental Medicine,Roseville MN 55113,American

出  处:《山东中医杂志》2017年第2期151-154,共4页Shandong Journal of Traditional Chinese Medicine

基  金:高等学校博士学科点专项科研基金(编号:200804410002)

摘  要:目的:探讨马钱子配伍苏木对佐剂性关节炎(AA)大鼠的免疫分子机制及较佳配比。方法 :马钱子与苏木不同配比水煎剂连续灌胃给药32 d,取血和滑膜组织,观察滑膜组织病理变化,采用酶联免疫吸附法(Elisa)测定血清中白介素-1β、白介素-6、白介素-10(IL-1β、IL-6、IL-10)、循环免疫复合物(CIC)、肿瘤坏死因子(TNF-α)、C型反应蛋白(CRP);通过逆转录-聚合酶链反应(RT-PCR)的方法,检测AA大鼠滑膜IL-1β、IL-10、TNF-αm RNA的表达情况。结果:不同配比的马钱子与苏木煎剂,能改善AA大鼠的滑膜充血、炎细胞浸润等病理变化,不同程度降低炎性细胞因子IL-1β、TNF-α、IL-6、CIC、CRP的含量;降低IL-1βm RNA的表达,上调IL-10 m RNA的表达。结论 :马钱子与苏木配伍对AA大鼠具有一定抗炎作用,其机制为抑制炎性细胞因子,控制炎症反应,其较佳配比为1∶6。Objective:To discuss the anti-inflammatory and immunologic mechanism on rats with adjuvant arthritis(AA) treated with Maqianzi and Sumu,and to determine the optimized ratio of Maqianzi to Sumu.Methods:AA model rats were given decoction of Maqianzi and Sumu with different ratio through gavage for32 days. Synovial tissue was under pathological examination. Changes of interleukin-1β,-6,10(IL-1β,IL-6,IL-10),tumor necrosis factor-α(TNF-α),circulating immune complex(CIC),C reactive protein(CRP) in serum were tested through ELISA,and m RNA expression of IL-1β,IL-10,TNF-α were detected through polymerase chain reaction(PCR). Results:Maqianzi and Sumu combined together in different ratio could obviously reduce the content of IL-1β,IL-6,TNF-α,CIC,CRP,decrease the expression level of IL-1β and increase IL-10. Conclusion:Maqianzi and Sumu in combination had certain anti-inflammatory function,through suppressing inflammatory cytokines,and the optimized ratio was 1 to 6.

关 键 词:马钱子 苏木 配伍 细胞因子 免疫机制 

分 类 号:R285.5[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象